SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HELIX BIOPHARMA (HBP:TSE)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: trustmanic who wrote (10)4/1/1997 1:01:00 PM
From: burner   of 193
 
Welcome aboard--It's good to have a "fan"!

I don't know if you can characterize Helix as a true biotech with a burn rate as they are revenue producing with cash flow. Their DNA lab is making money and their relationship wisth Bausch & Lomb also generates revenue as well as their lab products and diagnostic kits.

I believe we will see positive results within 6 months as some of the extraordinary expenses for licencing and initial marketing will be done with. The company once believed they would generate 12 M in fiscal 97 but the Health Protection Branch delays may affect those targets.

The company has about 5 and a half million from their last financing and will not go to the well until the share price is up considerably and more products and technologies are acquired.

There is a lot of support around $1.10 so this could be an entry level for you. Call the company and ask to speak to IR and also Terry Owen. Good people who are running a good show.
Good luck and don't forget to check out their website.
Dan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext